Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Oct;12(10):1681-8.
doi: 10.2174/138920111798357438.

Metabotropic glutamate receptors as targets for analgesia: antagonism, activation, and allosteric modulation

Michael C Montana  1 , Robert W Gereau
Affiliations
Review

Metabotropic glutamate receptors as targets for analgesia: antagonism, activation, and allosteric modulation

Michael C Montana et al. Curr Pharm Biotechnol. 2011 Oct.

Abstract

The metabotropic glutamate receptors (mGluRs) are expressed pre- and post-synaptically throughout the nervous system where they serve as modulators of synaptic transmission and neuronal excitability. Activation of mGluRs can be pro- or anti-nociceptive, depending on their anatomic location and the signaling cascades to which they couple. Antagonists of Group I mGluRs and agonists of Group II and III mGluRs have shown therapeutic promise in animal pain models. This article reviews the potential therapeutic utility of several agents that act predominantly via mGluRs, specifically focusing on their analgesic efficacy and discussing possible off-target effects. Glutamate, the primary excitatory neurotransmitter in the vertebrate nervous system, mediates its effects via activation of two main classes of receptors: ligand-gated ion channels known as ionotropic receptors and G-protein coupled metabotropic receptors. Antagonists of ionotropic glutamate receptors, such as ketamine, have robust analgesic properties; however, their analgesic utility is limited to monitored clinical settings due to the potential for psychomimetic effects.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Masu M, Tanabe Y, Tsuchida K, Shigemoto R, Nakanishi S. Sequence and expression of a metabotropic glutamate receptor. Nature. 1991;349(6312):760–765. - PubMed
    1. Varney MA, Gereau RWt. Metabotropic glutamate receptor involvement in models of acute and persistent pain: prospects for the development of novel analgesics. Current drug targets. 2002;1(3):283–296. - PubMed
    1. Bhave G, Karim F, Carlton SM, Gereau RWt. Peripheral group I metabotropic glutamate receptors modulate nociception in mice. Nature neuroscience. 2001;4(4):417–423. - PubMed
    1. Conn PJ. Physiological roles and therapeutic potential of metabotropic glutamate receptors. Annals of the New York Academy of Sciences. 2003;1003:12–21. - PubMed
    1. Knoflach F, Kemp JA. Metabotropic glutamate group II receptors activate a G protein-coupled inwardly rectifying K+ current in neurones of the rat cerebellum. The Journal of physiology. 1998;509(Pt 2):347–354. - PMC - PubMed

Publication types